New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 1, 2014
13:39 EDTAGN, CS, VRXPershing Square enlists Credit Suisse to help in Allergan effort, WSJ says
William Ackman's Pershing Square has hired Credit Suisse (CS), which is a firm known to have expertise in defending corporate clients against activist investors, for advice on the effort to have Valeant Pharmaceuticals (VRX) take over Allergan (AGN), says the Wall Street Journal. Reference Link
News For AGN;VRX;CS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
July 26, 2015
18:22 EDTAGNMedia reports say Teva to buy Allergan unit as it looks beyond Mylan
Subscribe for More Information
12:39 EDTAGNAllergan to acquire Naurex, plans research collaboration with Naurex spinoff
Subscribe for More Information
12:30 EDTAGNTeva nears deal to buy Allergan generics unit for $40.5B, Bloomberg says
Teva (TEVA) is nearing a deal to buy Allergan's (AGN) generic drug unit for roughly $40.5B and an agreement could be announced as early as Monday, reports Bloomberg, citing people familiar with the matter. Sources said Teva also plans to withdraw its bid for Mylan (MYL) as soon as Monday. Reference Link
12:17 EDTAGNTeva to cancel Mylan bid, plans offer for Allergan generics unit, Bloomberg says
Subscribe for More Information
July 24, 2015
18:36 EDTAGNAllergan considers split into two businesses, Bloomberg reports
Subscribe for More Information
18:25 EDTAGNAllergan considering breakup of company, Bloomberg reports
Allergan is reportedly working with advisors and leaning towards a sale or spinoff of generics, Bloomberg added.
07:06 EDTVRXValeant price target raised to $285 from $255 at UBS
Subscribe for More Information
06:51 EDTVRXValeant price target raised to $290 from $250 at JPMorgan
JPMorgan analyst Chris Schott raised his price target for Valeant Pharmaceuticals to $290 citing the company's "very strong" Q2 results. Schott sees further upside to estimates and reiterates an Overweight rating on the stock.
July 23, 2015
12:12 EDTVRXValeant beats RBC as biggest Canadian company by market value, Bloomberg says
Valeant (VRX) has surpassed Royal Bank of Canada (RY) as the largest Canadian company by market value on the Toronto Stock Exchange, Bloomberg reports. Valeant surged 4.5% to a total market value of C$111.3B at 11:21 AM in Toronto, beating the Royal Bank's C$108.3B market value, the report says. Reference Link
06:29 EDTVRXValeant raises FY15 cash EPS view to $11.5-$11.80 from $10.90-$11.20
Subscribe for More Information
06:26 EDTVRXValeant sees Q4 cash EPS $3.98-$4.18, consensus $3.49
Sees Q4 revenue $3.2B-$3.4B, consensus $3.03B.
06:25 EDTVRXValeant sees Q3 cash EPS $2.60-$2.70, consensus $2.86
Sees Q3 revenue $2.6B-$2.8B, consensus $2.74B.
06:24 EDTVRXValeant reports Q2 cash EPS $2.56, consensus $2.46
Subscribe for More Information
06:06 EDTVRXValeant raises FY15 cash EPS to $11.50-$11.80 from $10.90-$11.20
The increased EPS guidance reflects continued business outperformance and approval of IBS-D indication for Xifaxan. Raises FY15 total revenue to $10.7B-$10.4B from $10.4B-$10.6B. Sees FY15 Salix revenue $1.2B. Raises FY15 adjusted cash flow from operations to be greater than $3.2B from greater than $3.1B. Sees FY15 SSS organic growth of greater than 10% for 2H15.
06:05 EDTVRXValeant sees Q4 cash EPS $3.98-$4.18, revenue $3.2B-$3.4B
Subscribe for More Information
06:05 EDTVRXValeant sees Q3 cash EPS $2.60-$2.70, revenue $2.6B-$2.8B
Subscribe for More Information
06:04 EDTVRXValeant reports Q2 GAAP EPS (15c), Q2 cash EPS $2.56
Excluding negative impact of ForEx and Salix, cash EPS would have been $2.73. Reports Q2 total revenue $2.73B vs. $2.04B last year. Reports Q2 Product sales $2.70B vs. $1.99B last year. Reports Q2 SSS organic growth up 19%. Reports Q2 Salix revenue $313M.
05:47 EDTCSCredit Suisse reports Q2 EPS CHF 0.61 vs. (CHF 0.45) last year
Subscribe for More Information
July 22, 2015
09:59 EDTCSCredit Suisse CEO considers possible acquisition, FT reports
Subscribe for More Information
July 21, 2015
10:01 EDTVRXOn The Fly: Analyst Initiation Summary
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use